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Abstract
Factors contributing to Pakistan’s poor progress in reducing reproductive, maternal, newborn, and child health
(RMNCH) include its low level of female literacy, gender inequity, political challenges, and extremism along with
its associated relentless violence; further, less than 1% of Pakistan’s GDP is allocated to the health sector.
However, despite these disadvantages, Pakistani researchers have been able to achieve positive contributions
towards RMNCH-related global knowledge and evidence base, in some cases leading to the formulation of WHO
guidelines, for which they should feel proud. Nevertheless, in order to improve the health of its own women and
children, greater investments in human and health resources are required to facilitate the generation and use of
policy-relevant knowledge. To accomplish this, fair incentives for research production need to be introduced,
policy and decision-makers’ capacity to demand and use evidence needs to be increased, and strong support
from development partners and the global health community must be secured.
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Background
Pakistan is the sixth most populous country in the world.
With the second and third highest rates of stillbirths and
newborn mortality [1], respectively, its progress towards
achieving the targets specified in Millennium Develop-
ment Goals 4 and 5 has been slow. Despite pioneering the
launch of a family planning programme in the 1960s [2],
Pakistan has a poor record in the reproductive health
management of its own population. Nevertheless, the
Pakistani health community deserves credit for its role in
the reduction of the global burden of reproductive, mater-
nal, newborn, and child health (RMNCH).
An adequate appreciation of Pakistan’s achievements
and contributions requires that they be reviewed in
context. Factors contributing to Pakistan’s poor pro-
gress in reducing RMNCH include its low level of
female literacy, gender inequity, political challenges,
and extremism with its associated relentless violence.
Further, less than 1% of Pakistan’s GDP is allocated to
the health sector [3]. Its expenditure record is certainly
not outstanding, even compared to neighbouring coun-
tries with relatively poorer economic indicators, but it
is reasonable given the challenges it continues to face.
Notwithstanding, despite poor progress on the home
front, the Pakistani health community, especially its
RMNCH researchers, has contributed significantly to
the global knowledge and evidence base in this field
(Figure 1).
Unfortunately, these achievements have not been widely
recognized, neither by national policy and decision-makers
nor by the global health community at large. Exceptions in-
clude recognition by Richard Horton, editor of the Lancet
and a keen observer of global knowledge power, through
his acknowledgment of Pakistan’s contribution: “Pakistan
is a phenomenally research-productive nation, which has
delivered important innovations in health services, and has
produced leaders in health who have made a demonstrable
difference both domestically and internationally” [4]. To
further prove this point, the present commentary provides
selected examples of studies conducted and published by
Pakistani researchers in the field of RMNCH, which have
not only contributed to global knowledge, but have also
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been used as primary sources of evidence to formulate
WHO guidelines in this area.
Pakistani contributions to the field of reproductive,
maternal, newborn, and child health (RMNCH)
In the late 1980s, Pakistan was part of an 11-country study
on the aetiology of childhood pneumonia [5,6], which
contributed to the development of the WHO standard
pneumonia treatment guidelines [7] and the Haemophilus
influenzae B and pneumococcal vaccines. Pioneering work
by Pakistan’s National Institute of Health and National
Acute Respiratory Infection Control Programme in the
1990s [8] led to examination of the relationship between
in vitro antimicrobial resistance and in vivo outcomes for
clinical pneumonia as children responded clinically to oral
co-trimoxazole [9]. A randomised controlled trial (RCT)
showed that co-trimoxazole and amoxicillin were equally
effective in treating pneumonia associated with fast
breathing in hospitalized children and that children with
high in vitro antimicrobial resistance were cured with oral
co-trimoxazole [10]. An additional finding that amoxicillin
was twice as effective as co-trimoxazole for pneumonia
with chest in-drawing was very important at a time when
WHO guidelines recommended all children with chest
in-drawing pneumonia be hospitalized for injectable
antibiotic therapy [11]. A RCT in eight low- and middle-
income countries [12] and in Pakistan [13] showed that
oral amoxicillin was as effective as injectable penicillin/
ampicillin for pneumonia with chest in-drawing in chil-
dren aged 2–59 months. These results had a far-reaching
impact in 2012 when WHO revised pneumonia treatment
guidelines, recommending that oral amoxicillin be used to
treat pneumonia with chest in-drawing on an outpatient
basis in low-HIV settings [14]. Data from Pakistan also
contributed to the revision of WHO guidelines [15] for
the management of children with wheeze [16] and for
shortening antibiotic treatment for fast-breathing pneu-
monia from 5 to 3 days [17] in order to reduce the scope
for the development of antimicrobial resistance.
In reproductive health, Pakistani researchers have been
central to many ground-breaking international studies
which have influenced the design and implementation of
reproductive health programmes. The most important
among these is the Antenatal Corticosteroid Treatment
trial from the National Institute of Child Health and Hu-
man Development group [18], which has served as a pri-
mary source informing the development of new, as yet
unpublished WHO guidelines on the use of antenatal
corticosteroids for the prevention of pre-term births.
Cognizant of the scarcity of ultrasonography equipment
in remote rural areas, Pakistani researchers have initi-
ated studies to compare the accuracy of gestational age
estimates obtained through ultrasonography with those
obtained through history and physical examination [19].
They have also been pioneers in the study of mental
health issues among pregnant women, evident from the
work of Karmaliani et al. from Hyderabad and Sind
[20,21], as well as forming part of large multi-country
studies, such as that by Bloch et al. [22], to examine to-
bacco use and second-hand smoke prevalence among
pregnant women.
Pakistan has also been a global leader in community-
based strategies to expand access to RMNCH services.
Learning from its lady health worker (LHW) programme,
many countries have adopted integrated community-case
management of common childhood illnesses as a strategy
[23]. Additionally, with appropriate training, supervision,
and regular supplies, LHWs have managed pneumonia
with chest in-drawing in children aged 2–59 months at
the community level in two cluster RCTs with low treat-
ment failure rates and mortality [24,25]; these findings are
the first of their kind globally and have stimulated further
research (Personal Communication, Shamim Qazi, WHO
HQ, Geneva, Switzerland). LHWs have also contributed
to the reduction of perinatal mortality through the
provision of services in the community [26], which has
contributed to the development of WHO recommenda-
tions for home visits in the first week of life [15].
Figure 1 Research publications on reproductive, maternal, newborn, and child health in Pakistan, 2000–2014.
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Conclusions
Pakistani researchers have been able to contribute to
RMNCH-related global knowledge and evidence base in
the face of challenging conditions, and they should feel
proud of these achievements despite the fact that the
current state of RMNCH affairs in Pakistan does not
offer exciting or satisfying prospects. Pakistan needs to
invest in human and health-related resources to generate
and use policy-relevant knowledge for its own popula-
tion. In order for Pakistan to reduce the national burden
of RMNCH it must be able to apply research evidence
for improved policymaking. Therefore, it is essential that
appropriate funding, fair incentives for research produc-
tion, appropriate recognition by the government, im-
proved capacities for policy- and decision-makers to
demand and use evidence, and strong support from the
development community are all urgently required.
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